DD
Dhaval Dhirajlal Akbari
About Dhaval Dhirajlal Akbari
Data last updated:
Dhaval Dhirajlal Akbari is a Director at Mederal Pharmaceuticals Private Limited (since 2018). The companies operate in Healthcare and Manufacturing. Mederal Pharmaceuticals Private Limited reported revenue of ₹12.25 Cr (FY 2025). Earlier, Dhaval Dhirajlal Akbari was a Director at Skyart Paints Private Limited (2018–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mederal Pharmaceuticals Private Limited U24302MH2018PTC308447 | Director | 24 Apr 2018 | 2018 | ₹12.25 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Skyart Paints Private Limited U24304GJ2018PTC102118 | Director | 20 Jun 2018 | 2018 | ₹42.4 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dhaval Dhirajlal Akbari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nitinn Satyendra Gupta | 06938425 | Mederal Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dhaval Dhirajlal Akbari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhaval Dhirajlal Akbari
Dhaval Dhirajlal Akbari currently holds 1 directorship: Mederal Pharmaceuticals Private Limited (Director, since 24 Apr 2018, revenue ₹12.25 Cr (FY 2025)).
Dhaval Dhirajlal Akbari was first appointed on 24 Apr 2018 as Director at Mederal Pharmaceuticals Private Limited.
Dhaval Dhirajlal Akbari held 1 earlier board appointment: Skyart Paints Private Limited (Director, 20 Jun 2018 to 23 Mar 2021).
The current boards of Dhaval Dhirajlal Akbari's companies include Nitinn Satyendra Gupta (Mederal Pharmaceuticals Private Limited).